Is hepatitis C associated with atherosclerotic burden? A Systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Huang, He ^a   Kang, Rongyan ^a   Zhao, Zhendong ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMORAL ARTERY; FEMORAL ATHEROSCLEROSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); COMPLICATION; HEPACIVIRUS; META ANALYSIS; PATHOGENICITY; PATHOLOGY; RISK FACTOR; VIROLOGY;

HEPATITIS C VIRUS;

ATHEROSCLEROSIS; HEPACIVIRUS; HEPATITIS C; HUMANS; RISK FACTORS;

EID: 84906964369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106376     Document Type: Article

References (45)

1. Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20: 1-16.
2. Zein CO, Levy C, Basu A, Zein NN (2005) Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 100: 48-55.
3. White DL, Ratziu V, El-Serag HB (2008) Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 49: 831-844.
4. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, et al. (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297: 2010-2017.
5. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, et al. (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6: 451-458.
6. Daghestani L, Pomeroy C (1999) Renal manifestations of hepatitis C infection. Am J Med 106: 347-354.
7. Louie KS, St Laurent S, Forssen UM, Mundy LM, Pimenta JM (2012) The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis 12: 86.
8. Pateria P, Ching H, Macquillan G, Jeffrey GP, Watts G, et al. (2013) Association between chronic hepatitis C infection and vascular risk and function. Journal of Gastroenterology and Hepatology 28: 161.
9. Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A, et al. (2013) Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 231: 22-26.
10. Kakinami L, Block RC, Adams MJ, Cohn SE, Maliakkal B, et al. (2013) Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population. Int J Clin Pract 67: 6-13.
11. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, et al. (2009) Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 49: 225-232.
12. Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, et al. (2008) Increased all-cause, liver, and cardiac mortality among hepatitis C virusseropositive blood donors. Am J Epidemiol 167: 743-750.
13. Lee MH, Yang HI, Jen CL, Wang CH, Chiou YM, et al. (2009) Hepatitis C virus infection and cerebrovascular disease mortality. Journal of Hepatology 50: S153.
14. Adinolfi LE, Restivo L, Zampino R, Guerrera B, Lonardo A, et al. (2012) Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis 221: 496-502.
15. Alyan O, Kacmaz F, Ozdemir O, Deveci B, Astan R, et al. (2008) Hepatitis C Infection is Associated With Increased Coronary Artery Atherosclerosis Defined by Modified Reardon Severity Score System. Circulation Journal 72: 1960-1965.
16. Boddi M, Abbate R, Chellini B, Giusti B, Solazzo V, et al. (2007) HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Digestive & Liver Disease 39 Suppl 1: S55-60.
17. Ishizaka N, Ishizaka Y, Takahashi E, Tooda EI, Hashimoto H, et al. (2002) Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359: 133-135.
18. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E-i, et al. (2003) Association between hepatitis C virus core protein and carotid atherosclerosis. Circulation Journal 67: 26-30.
19. Mostafa A, Mohamed MK, Saeed M, Hasan A, Fontanet A, et al. (2010) Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut 59: 1135-1140.
20. Petta S, Torres D, Fazio G, Camma C, Cabibi D, et al. (2012) Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology 55: 1317-1323.
21. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, et al. (2007) Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. Journal of Hepatology 46: 1126-1132.
22. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T (2003) Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 289: 1245-1246.
23. Tomiyama H, Arai T, Hirose K-i, Hori S, Yamamoto Y, et al. (2003) Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis 166: 401-403.
24. Momiyama Y, Ohmori R, Kato R, Taniguchi H, Ohsuzu F, et al. (2005) Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease [2]. Atherosclerosis 181: 211-213.
25. Tien PC, Schneider MF, Cole SR, Cohen MH, Glesby MJ, et al. (2009) Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study. AIDS 23: 1781-1784.
26. Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, et al. (2014) Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C - a cross-sectional study. Vascular Health and Risk Management 10: 55-61.
27. Volzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, et al. (2004) Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 174: 99-103.
28. Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, et al. (2009) Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clinical Nephrology 71: 147-157.
29. Bilora F, Campagnolo E, Rinaldi R, Rossato A, Arzenton M, et al. (2008) Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up. Angiology 59: 717-720.
30. Aslam F, Alam M, Lakkis NM (2010) Hepatitis C and carotid atherosclerosis: a retrospective analysis. Atherosclerosis 209: 340-343.
31. Roed T, Lebech AM, Kjaer A, Weis N (2012) Hepatitis C virus infection and risk of coronary artery disease: A systematic review of the literature. Clinical Physiology and Functional Imaging 32: 421-430.
32. Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, et al. (2014) Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol 20: 3410-3417.
33. Wong RJ, Kanwal F, Younossi ZM, Ahmed A (2014) Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature. Dig Dis Sci 59: 1586-1593.
34. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0 [Updated March 2011]. The Cochrane Collaboration.
35. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
36. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
37. Normand SL (1999) Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18: 321-359.
38. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
39. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991) Publication bias in clinical research. Lancet 337: 867-872.
40. Masia M, Padilla S, Robledano C, Ramos JM, Gutierrez F (2011) Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study. BMC Infectious Diseases 11: 265.
41. Sosner P, Wangermez M, Chagneau-Derrode C, Le Moal G, Silvain C (2012) Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis 222: 274-277.
42. He H, Kang R, Zhao Z (2013) Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS ONE 8: e81305.
43. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, et al. (2010) Hepatitis C virus RNA localization in human carotid plaques. Journal of Clinical Virology 47: 72-75.
44. Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89: 763-771.
45. Oliveira CP, Kappel CR, Siqueira ER, Lima VM, Stefano JT, et al. (2013) Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol 164: 221-226.